Compare · EW vs HDSN
EW vs HDSN
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Hudson Technologies Inc. (HDSN): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while HDSN operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $49.43B, about 215.6x HDSN ($229.3M).
- Over the past year, EW is up 12.5% and HDSN is down 25.3% - EW leads by 37.8 points.
- Both names hit the wire about 7 times in the past 4 weeks.
- EW has more recent analyst coverage (25 ratings vs 11 for HDSN).
- Company
- Edwards Lifesciences Corporation
- Hudson Technologies Inc.
- Price
- $85.84-0.14%
- $5.45+1.77%
- Market cap
- $49.43B
- $229.3M
- 1M return
- +3.72%
- +2.83%
- 1Y return
- +12.46%
- -25.34%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 7
- Recent ratings
- 25
- 11
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Hudson Technologies Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
Latest EW
- SEC Form 3 filed by new insider Mistras Theodora
- SVP, Corporate Controller Dahl Andrew M. sold $48,853 worth of shares (568 units at $86.08), decreasing direct ownership by 4% to 15,334 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $2,000,193 worth of shares (23,145 units at $86.42) (SEC Form 4)
- SEC Form SD filed by Edwards Lifesciences Corporation
- CVP, TMTT & Surgical Chopra Daveen sold $126,905 worth of shares (1,500 units at $84.60), decreasing direct ownership by 3% to 44,324 units (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 620 shares at a strike of $72.68 and sold $50,307 worth of shares (620 units at $81.14) as part of a pre-agreed trading plan (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $1,472,678 worth of shares (17,968 units at $81.96), decreasing direct ownership by 30% to 22,798 units (SEC Form 4)
- CEO Zovighian Bernard J converted options into 47,207 shares, covered exercise/tax liability with 26,198 shares, gifted 26,640 shares, received a gift of 26,640 shares and sold $2,833,013 worth of shares (36,351 units at $77.93) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 99,165 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr converted options into 13,457 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 22% to 32,766 units (SEC Form 4)
- CVP, TMTT & Surgical Chopra Daveen converted options into 13,583 shares and covered exercise/tax liability with 7,538 shares, increasing direct ownership by 15% to 45,824 units (SEC Form 4)
Latest HDSN
- Hudson Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Hudson Technologies Receives Extension of Contract with the United States Defense Logistics Agency
- Amendment: Director Parrillo Richard bought $48,257 worth of shares (10,000 units at $4.83), increasing direct ownership by 5% to 195,746 units (SEC Form 4)
- Chief Financial Officer Bertaux Brian J. bought $9,740 worth of shares (2,000 units at $4.87) (SEC Form 4)
- Hudson Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Hudson Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Hudson Technologies Announces Open Market Share Purchases by the Board and Senior Management
- Director Mansy Loan Nguyen bought $24,814 worth of shares (5,000 units at $4.96), increasing direct ownership by 24% to 25,595 units (SEC Form 4)
- Director Parrillo Richard bought $24,814 worth of shares (5,000 units at $4.96), increasing direct ownership by 24% to 25,595 units (SEC Form 4)
- Director Bulgarino Nicole E bought $2,665 worth of shares (550 units at $4.84), increasing direct ownership by 5% to 11,048 units (SEC Form 4)